Chinese scientists and US leadership in the life sciences von Holtzman, Steven H., Cohen, Ron, Levin, Jeremy M., Maraganore, John

Volltext

A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma von Scheu, Kelly, Chiu, Rita, Ritter, Erika, Kachel, Jennifer, Lowy, Israel, Old, Lloyd J., Ritter, Gerd, Maki, Robert G., Wagner, Michael J., Keohan, Mary Louise, D’Adamo, David R., Jungbluth, Achim A., Gnjatic, Sacha, Schwartz, Gary K.

Volltext

Anti-PD-1 immunotherapy with ADT induces robust immune infiltration in Metastatic Castration-Sensitive Prostate Cancer von Obradovic, Aleksandar

Volltext bestellen

Anti-PD-1 immunotherapy with ADT induces robust immune infiltration in Metastatic Castration-Sensitive Prostate Cancer von Obradovic, Aleksandar

Volltext bestellen

CELL LINEAGE ASED IMMUNOGEN DESIGN WITH HUMANIZED ANIMALS von John MCWHIRTER J, Andrew J. MURPHY AJ, Karolina A. MEAGHER KA, Aris I. BARAS AI, George D. YANCOPOULOS GD, Garnett KELSOE G, Israel LOWY I, Barton HAYNES B, Lynn MACDONALD L, Cagan GURER C

Volltext bestellen

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma von Gross, Neil D., Miller, David M., Khushalani, Nikhil I., Divi, Vasu, Ruiz, Emily S., Lipson, Evan J., Meier, Friedegund, Su, Yungpo B., Swiecicki, Paul L., Atlas, Jennifer, Geiger, Jessica L., Hauschild, Axel, Choe, Jennifer H., Hughes, Brett G.M., Schadendorf, Dirk, Patel, Vishal A., Homsi, Jade, Taube, Janis M., Lim, Annette M., Ferrarotto, Renata, Kaufman, Howard L., Seebach, Frank, Lowy, Israel, Yoo, Suk-Young, Mathias, Melissa, Fenech, Keilah, Han, Hyunsil, Fury, Matthew G., Rischin, Danny

Volltext

Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma von ROYAL, Richard E, LEVY, Catherine, ROSENBERG, Steven A, TURNER, Keli, MATHUR, Aarti, HUGHES, Marybeth, KAMMULA, Udai S, SHERRY, Richard M, TOPALIAN, Suzanne L, YANG, James C, LOWY, Israel

Volltext

Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial von Gogishvili, Miranda, Melkadze, Tamar, Makharadze, Tamta, Giorgadze, Davit, Dvorkin, Mikhail, Penkov, Konstantin, Laktionov, Konstantin, Nemsadze, Gia, Nechaeva, Marina, Rozhkova, Irina, Kalinka, Ewa, Gessner, Christian, Moreno-Jaime, Brizio, Passalacqua, Rodolfo, Li, Siyu, McGuire, Kristina, Kaul, Manika, Paccaly, Anne, Quek, Ruben G. W., Gao, Bo, Seebach, Frank, Weinreich, David M., Yancopoulos, George D., Lowy, Israel, Gullo, Giuseppe, Rietschel, Petra

Volltext

Tumor-reprogrammed resident T cells resist radiation to control tumors von Arina, Ainhoa, Beckett, Michael, Fernandez, Christian, Zheng, Wenxin, Pitroda, Sean, Chmura, Steven J., Luke, Jason J., Forde, Martin, Hou, Yuzhu, Burnette, Byron, Mauceri, Helena, Lowy, Israel, Sims, Tasha, Khodarev, Nikolai, Fu, Yang-Xin, Weichselbaum, Ralph R.

Volltext

Nivolumab plus Ipilimumab in Advanced Melanoma von WOLCHOK, Jedd D, KLUGER, Harriet, BURKE, Matthew M, CALDWELL, Anne, KRONENBERG, Stephanie A, AGUNWAMBA, Blessing U, XIAOLING ZHANG, LOWY, Israel, INZUNZA, Hector David, FEELY, William, HORAK, Christine E, QUAN HONG, CALLAHAN, Margaret K, KORMAN, Alan J, WIGGINTON, Jon M, GUPTA, Ashok, SZNOL, Mario, POSTOW, Michael A, RIZVI, Naiyer A, LESOKHIN, Alexander M, SEGAL, Neil H, ARIYAN, Charlotte E, GORDON, Ruth-Ann, REED, Kathleen

Volltext

Survival with Cemiplimab in Recurrent Cervical Cancer von Tewari, Krishnansu S, Monk, Bradley J, Vergote, Ignace, Miller, Austin, de Melo, Andreia C, Kim, Hee-Seung, Kim, Yong Man, Lisyanskaya, Alla, Samouëlian, Vanessa, Lorusso, Domenica, Damian, Fernanda, Chang, Chih-Long, Gotovkin, Evgeniy A, Takahashi, Shunji, Ramone, Daniella, Pikiel, Joanna, Maćkowiak-Matejczyk, Beata, Guerra Alía, Eva M, Colombo, Nicoletta, Makarova, Yulia, Rischin, Danny, Lheureux, Stephanie, Hasegawa, Kosei, Fujiwara, Keiichi, Li, Jingjin, Jamil, Shaheda, Jankovic, Vladimir, Chen, Chieh-I, Seebach, Frank, Weinreich, David M, Yancopoulos, George D, Lowy, Israel, Mathias, Melissa, Fury, Matthew G, Oaknin, Ana

Volltext

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates von BRAHMER, Julie R, DRAKE, Charles G, GILSON, Marta M, CHANGYU WANG, SELBY, Mark, TAUBE, Janis M, ANDERS, Robert, LIEPING CHEN, KORMAN, Alan J, PARDOLL, Drew M, LOWY, Israel, TOPALIAN, Suzanne L, WOLLNER, Ira, POWDERLY, John D, PICUS, Joel, SHARFMAN, William H, STANKEVICH, Elizabeth, PONS, Alice, SALAY, Theresa M, MCMILLER, Tracee L

Volltext

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlle... von Sezer, Ahmet, Kilickap, Saadettin, Gümüş, Mahmut, Bondarenko, Igor, Özgüroğlu, Mustafa, Gogishvili, Miranda, Turk, Haci M, Cicin, Irfan, Bentsion, Dmitry, Gladkov, Oleg, Clingan, Philip, Sriuranpong, Virote, Rizvi, Naiyer, Gao, Bo, Li, Siyu, Lee, Sue, McGuire, Kristina, Chen, Chieh-I, Makharadze, Tamta, Paydas, Semra, Nechaeva, Marina, Seebach, Frank, Weinreich, David M, Yancopoulos, George D, Gullo, Giuseppe, Lowy, Israel, Rietschel, Petra

Volltext

A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus... von Gardiner, David, Lalezari, Jay, Lawitz, Eric, DiMicco, Michael, Ghalib, Rheem, Reddy, K Rajender, Chang, Kyong-Mi, Sulkowski, Mark, Marro, Steven O', Anderson, Jeffrey, He, Bing, Kansra, Vikram, McPhee, Fiona, Wind-Rotolo, Megan, Grasela, Dennis, Selby, Mark, Korman, Alan J, Lowy, Israel

Volltext

Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810 von Falchook, Gerald S., Leidner, Rom, Stankevich, Elizabeth, Piening, Brian, Bifulco, Carlo, Lowy, Israel, Fury, Matthew G.

Volltext

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resis... von van den Eertwegh, Alfons JM, MD, Versluis, Jurjen, MD, van den Berg, H Pieter, MD, Santegoets, Saskia JAM, PhD, van Moorselaar, R Jeroen A, Prof, van der Sluis, Tim M, MD, Gall, Helen E, MNAP, Harding, Thomas C, MD, Jooss, Karin, PhD, Lowy, Israel, MD, Pinedo, Herbert M, Prof, Scheper, Rik J, Prof, Stam, Anita GM, BSc, von Blomberg, B Mary E, PhD, de Gruijl, Tanja D, PhD, Hege, Kristen, MD, Sacks, Natalie, MD, Gerritsen, Winald R, Prof

Volltext

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing von Rischin, Danny, Migden, Michael R, Lim, Annette M, Schmults, Chrysalyne D, Khushalani, Nikhil I, Hughes, Brett G M, Schadendorf, Dirk, Dunn, Lara A, Hernandez-Aya, Leonel, Chang, Anne Lynn S, Modi, Badri, Hauschild, Axel, Ulrich, Claas, Eigentler, Thomas, Stein, Brian, Pavlick, Anna C, Geiger, Jessica L, Gutzmer, Ralf, Alam, Murad, Okoye, Emmanuel, Mathias, Melissa, Jankovic, Vladimir, Stankevich, Elizabeth, Booth, Jocelyn, Li, Siyu, Lowy, Israel, Fury, Matthew G, Guminski, Alexander

Volltext

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial von Migden, Michael R, Khushalani, Nikhil I, Chang, Anne Lynn S, Lewis, Karl D, Schmults, Chrysalyne D, Hernandez-Aya, Leonel, Meier, Friedegund, Schadendorf, Dirk, Guminski, Alexander, Hauschild, Axel, Wong, Deborah J, Daniels, Gregory A, Berking, Carola, Jankovic, Vladimir, Stankevich, Elizabeth, Booth, Jocelyn, Li, Siyu, Weinreich, David M, Yancopoulos, George D, Lowy, Israel, Fury, Matthew G, Rischin, Danny

Volltext

A Pilot Trial of CTLA-4 Blockade with Human Anti-CTLA-4 in Patients with Hormone-Refractory Prostate Cancer von SMALL, Eric J, TCHEKMEDYIAN, N. Simon, RINI, Brian I, FONG, Lawrence, LOWY, Israel, ALLISON, James P

Volltext

Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates von Brahmer, Julie R, Drake, Charles G, Wollner, Ira, Powderly, John D, Picus, Joel, Sharfman, William H, Stankevich, Elizabeth, Pons, Alice, Salay, Theresa M, McMiller, Tracee L, Gilson, Marta M, Wang, Changyu, Selby, Mark, Taube, Janis M, Anders, Robert, Chen, Lieping, Korman, Alan J, Pardoll, Drew M, Lowy, Israel, Topalian, Suzanne L

Volltext